Cell Therapy for Diabetes
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT06651515
A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 30, 2025
Completion: Mar 31, 2028
Loading map...